Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC13A3 | Q8WWT9 | 1/20 | 0.37 |
| ▸ | HTT | P42858 | 1/20 | 0.34 |
| ▸ | RAB9A | P51151 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21098770 | 0.86 | MAOB (0.33) | HTT | |
| SCHEMBL18467706 | 0.83 | — | — | |
| SCHEMBL18467680 | 0.81 | — | — | |
| SCHEMBL608122 | 0.79 | SLC13A3 (0.39) | SLC13A3HTTRAB9A | |
| SCHEMBL22759030 | 0.78 | — | — | |
| SCHEMBL21633236 | 0.77 | SLC13A3 (0.38) | SLC13A3HTTRAB9A | |
| SCHEMBL608123 | 0.77 | SLC13A3 (0.38) | SLC13A3HTTRAB9A | |
| SCHEMBL21357981 | 0.75 | ADRA2A (0.44) | SLC13A3HTTRAB9A | |
| SCHEMBL2823246 | 0.75 | SLC13A3 (0.40) | SLC13A3HTTRAB9A | |
| SCHEMBL124955 | 0.75 | ALDH1A1 (0.46) | SLC13A3HTTRAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11591362-B2 | Orthogonal protecting groups for the preparation of stereodefined phosphorothioate oligonucleotides | ROCHE INNOVATION CENTER COPENHAGEN A/S (DK) | 2023-02-28 | — | — | US | disclosed |
| US-11075408-B2 | Silicon-based energy storage devices with fluorinated polymer containing electrolyte additives | ENEVATE CORPORATION (US) | 2021-07-27 | — | — | US | disclosed |
| US-20210179658-A1 | ORTHOGONAL PROTECTING GROUPS FOR THE PREPARATION OF STEREODEFINED PHOSPHOROTHIOATE OLIGONUCLEOTIDES | ROCHE INNOVATION CENTER COPENHAGEN A/S (DK) | 2021-06-17 | — | — | US | disclosed |
| US-20190181500-A1 | SILICON-BASED ENERGY STORAGE DEVICES WITH FLUORINATED POLYMER CONTAINING ELECTROLYTE ADDITIVES | ENEVATE CORPORATION | 2019-06-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210179658-A1 | ORTHOGONAL PROTECTING GROUPS FOR THE PREPARATION OF STEREODEFINED PHOSPHOROTHIOATE OLIGONUCLEOTIDES | PCNA, RNGTT, POLL | SLC13A3 1861/4885HTT 1800/4885RAB9A 4560/4885 |
| US-11591362-B2 | Orthogonal protecting groups for the preparation of stereodefined phosphorothioate oligonucleotides | PCNA, RNGTT, POLL | SLC13A3 1861/4885HTT 1800/4885RAB9A 4560/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.